Coinspeaker Moderna (MRNA) Stock Climbs 23% as World Is Waiting for the Coronavirus Vaccine ResultsWith coronavirus outbreak spreading a lot of fears to the global investors, talks of a vaccine are bolstering the Moderna (MRNA) stock value. However, it is still an early call, as the vaccine takes over a year to go through the regulatory testing rounds.Moderna (MRNA) Stock Climbs 23% as World Is Waiting for the Coronavirus Vaccine Results
